Ultramed secures pre seed funding to expand health assessment technology

Ultramed Limited, a health technology company based in Penryn, Cornwall, has successfully closed a funding round totalling £52,000. The investment gives the business an estimated post money valuation of £8m. The company is best known for its Ultraprep suite, a digital platform designed to streamline the pre operative process by allowing patients to complete health assessments from their own homes. This latest injection of capital will support the ongoing development of their patient facing software as the company continues to integrate its services within the healthcare sector. Founded in September 2014, Ultramed was established to tackle the inefficiencies inherent in traditional hospital preoperative assessments. In many clinical settings, patients are required to attend physical appointments simply to provide medical histories and lifestyle information before a procedure. The Ultraprep technology solves this by providing a secure, online environment where patients can enter their data at their own pace. This information is then shared with healthcare providers, allowing clinicians to review the data remotely, identify potential surgical risks earlier, and reduce the number of unnecessary face to face consultations.

Operating from the South West of England, Ultramed has positioned itself as a key player in the regional Cornish technology ecosystem. The business model relies on providing a secure bridge between the patient and the hospital, ensuring that data privacy is maintained while clinical workflows are improved. The current funding round of £52,500 represents a pre seed investment. Based on recent share allotment data filed February 2026, this round establishes a post money valuation of £8m.

Within the broader UK funding landscape, the HealthTech sector continues to attract significant attention, particularly for companies that offer direct solutions to healthcare administrative burdens. In 2025.0 and early 2026.0, there has been a notable trend towards supporting companies that provide clear, demonstrable savings in clinical time and hospital resources. Ultramed fits this profile by digitising a traditionally paper heavy and time intensive part of the surgical journey.

The regional context is also important for this round. Penryn and the wider Cornwall area have seen a steady rise in technology led businesses, supported by local innovation hubs. Ultramed represents one of the more established entities in this regional cluster. This pre seed round serves as a reminder that vital health technology development is occurring across the UK, not just in the major metropolitan centres. With 18 staff members now working on the platform, the company is well positioned to leverage this new capital to further enhance the patient experience and clinical utility of the Ultraprep suite.